Changchun BCHT Biotechnology Co. (SHA:688276)

SHA:688276 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	224.1	344.87	442.18	866.54	1,156	309.63
Cash & Short-Term Investments	224.1	344.87	442.18	866.54	1,156	309.63
Cash Growth	-42.90%	-22.01%	-48.97%	-25.01%	273.22%	13.42%
Accounts Receivable	1,365	1,407	1,567	968.41	763.94	733.18
Other Receivables	-	2.09	-	-	-	-
Receivables	1,365	1,409	1,567	968.41	763.94	733.18
Inventory	211.2	170.78	199.02	192.11	241.34	146.19
Prepaid Expenses	-	-	0.92	0.1	-	-
Other Current Assets	65.63	40.24	35.26	30.81	29.15	32.25
Total Current Assets	1,866	1,965	2,245	2,058	2,190	1,221
Property, Plant & Equipment	2,539	2,478	2,085	1,642	1,439	783.08
Long-Term Investments	399.6	211.34	207.57	61.28	69.12	10.23
Other Intangible Assets	319.23	330.6	347.45	204.02	223.72	248.57
Long-Term Deferred Tax Assets	101.55	96.28	90.97	54.2	31.93	20.96
Long-Term Deferred Charges	71.83	74.68	29.26	211.09	159.25	121.57
Other Long-Term Assets	54.21	49.56	41.06	53.06	61.95	61.85
Total Assets	5,352	5,205	5,046	4,284	4,175	2,468
Accounts Payable	18.38	13.81	17.49	24.8	63.91	34
Accrued Expenses	19.63	28.07	553.18	340.9	422.69	486.26
Short-Term Debt	93.16	42.9	20.47	-	-	-
Current Income Taxes Payable	2.73	6.62	48.89	5.07	-	18.24
Current Unearned Revenue	0.97	2.2	0.28	8.65	10.21	6.25
Other Current Liabilities	910.25	823.46	374.56	337.27	251.89	134.94
Total Current Liabilities	1,045	917.07	1,015	716.68	748.71	679.69
Long-Term Debt	82.06	59.93	-	-	-	-
Long-Term Unearned Revenue	8.72	9	9.86	5.92	8.09	7.88
Long-Term Deferred Tax Liabilities	0.86	0.88	0.98	1.11	-	-
Other Long-Term Liabilities	0.26	0.24	0.17	0.31	0.25	-
Total Liabilities	1,137	987.12	1,026	724.02	757.05	687.57
Common Stock	413.66	413.66	412.84	412.84	412.84	371.56
Additional Paid-In Capital	1,841	1,840	1,820	1,778	1,771	416.29
Retained Earnings	1,990	1,989	1,819	1,380	1,240	1,023
Comprehensive Income & Other	-29.89	-25.27	-31.86	-10.96	-5.75	-30.89
Shareholders' Equity	4,215	4,218	4,020	3,560	3,418	1,780
Total Liabilities & Equity	5,352	5,205	5,046	4,284	4,175	2,468
Total Debt	175.22	102.83	20.47	-	-	-
Net Cash (Debt)	48.88	242.04	421.71	866.54	1,156	309.63
Net Cash Growth	-85.06%	-42.60%	-51.33%	-25.01%	273.22%	186.74%
Net Cash Per Share	0.12	0.58	1.02	2.10	2.94	0.84
Filing Date Shares Outstanding	413.66	415.25	412.84	412.84	412.84	371.56
Total Common Shares Outstanding	413.66	415.25	412.84	412.84	412.84	371.56
Working Capital	821.22	1,048	1,230	1,341	1,441	541.56
Book Value Per Share	10.19	10.16	9.74	8.62	8.28	4.79
Tangible Book Value	3,896	3,887	3,673	3,356	3,194	1,531
Tangible Book Value Per Share	9.42	9.36	8.90	8.13	7.74	4.12
Buildings	-	-	487.92	374.62	307.51	324.89
Machinery	-	-	826.34	509.79	451.85	426.37
Construction In Progress	-	-	1,101	1,038	919.84	235.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.